11-72105937-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001145309.4(LRTOMT):c.85G>A(p.Ala29Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,385,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001145309.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRTOMT | NM_001145309.4 | c.85G>A | p.Ala29Thr | missense_variant, splice_region_variant | 7/9 | NP_001138781.1 | ||
TOMT | NM_001393500.2 | c.-15G>A | 5_prime_UTR_variant | 1/3 | ENST00000541899.3 | NP_001380429.1 | ||
LRTOMT | NM_001145308.5 | c.85G>A | p.Ala29Thr | missense_variant, splice_region_variant | 5/7 | NP_001138780.1 | ||
LRTOMT | NM_001145310.4 | c.84-119G>A | intron_variant | NP_001138782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOMT | ENST00000541899.3 | c.-15G>A | 5_prime_UTR_variant | 1/3 | 5 | NM_001393500.2 | ENSP00000494667 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000659 AC: 1AN: 151676Hom.: 0 AF XY: 0.0000124 AC XY: 1AN XY: 80506
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1385366Hom.: 0 Cov.: 31 AF XY: 0.00000294 AC XY: 2AN XY: 680530
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at